<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>cardiovascular medicine</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>cardiovascular medicine | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Deep neural network for identification of impaired microvascular and vasomotor function from stress electrocardiography
Authors: Moody, J. B.; Poitrasson-Riviere, A.; Renaud, J. M.; Hagio, T.; Alahdab, F.; Al-Mallah, M. H.; Vanderver, M. D.; Ficaro, E. P.; Murthy, V. L.
Score: 1.2, Published: 2023-10-25 DOI: 10.1101/2023.10.25.23297552
Background: Impaired microvascular and vasomotor function is a common consequence of aging, diabetes, and other risk factors, and is associated with adverse cardiac outcomes. Such impairments are not readily identified by standard clinical methods of cardiovascular testing such as coronary angiography and noninvasive single photon emission tomography (SPECT) myocardial perfusion imaging (MPI).">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/cardiovascular-medicine/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="cardiovascular medicine" />
<meta property="og:description" content="Deep neural network for identification of impaired microvascular and vasomotor function from stress electrocardiography
Authors: Moody, J. B.; Poitrasson-Riviere, A.; Renaud, J. M.; Hagio, T.; Alahdab, F.; Al-Mallah, M. H.; Vanderver, M. D.; Ficaro, E. P.; Murthy, V. L.
Score: 1.2, Published: 2023-10-25 DOI: 10.1101/2023.10.25.23297552
Background: Impaired microvascular and vasomotor function is a common consequence of aging, diabetes, and other risk factors, and is associated with adverse cardiac outcomes. Such impairments are not readily identified by standard clinical methods of cardiovascular testing such as coronary angiography and noninvasive single photon emission tomography (SPECT) myocardial perfusion imaging (MPI)." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/cardiovascular-medicine/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-10-29T10:37:40+00:00" />
<meta property="article:modified_time" content="2023-10-29T10:37:40+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="cardiovascular medicine"/>
<meta name="twitter:description" content="Deep neural network for identification of impaired microvascular and vasomotor function from stress electrocardiography
Authors: Moody, J. B.; Poitrasson-Riviere, A.; Renaud, J. M.; Hagio, T.; Alahdab, F.; Al-Mallah, M. H.; Vanderver, M. D.; Ficaro, E. P.; Murthy, V. L.
Score: 1.2, Published: 2023-10-25 DOI: 10.1101/2023.10.25.23297552
Background: Impaired microvascular and vasomotor function is a common consequence of aging, diabetes, and other risk factors, and is associated with adverse cardiac outcomes. Such impairments are not readily identified by standard clinical methods of cardiovascular testing such as coronary angiography and noninvasive single photon emission tomography (SPECT) myocardial perfusion imaging (MPI)."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "cardiovascular medicine",
      "item": "https://trxiv.yorks0n.com/posts/cardiovascular-medicine/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "cardiovascular medicine",
  "name": "cardiovascular medicine",
  "description": "Deep neural network for identification of impaired microvascular and vasomotor function from stress electrocardiography\nAuthors: Moody, J. B.; Poitrasson-Riviere, A.; Renaud, J. M.; Hagio, T.; Alahdab, F.; Al-Mallah, M. H.; Vanderver, M. D.; Ficaro, E. P.; Murthy, V. L.\nScore: 1.2, Published: 2023-10-25 DOI: 10.1101/2023.10.25.23297552\nBackground: Impaired microvascular and vasomotor function is a common consequence of aging, diabetes, and other risk factors, and is associated with adverse cardiac outcomes. Such impairments are not readily identified by standard clinical methods of cardiovascular testing such as coronary angiography and noninvasive single photon emission tomography (SPECT) myocardial perfusion imaging (MPI).",
  "keywords": [
    
  ],
  "articleBody": " Deep neural network for identification of impaired microvascular and vasomotor function from stress electrocardiography\nAuthors: Moody, J. B.; Poitrasson-Riviere, A.; Renaud, J. M.; Hagio, T.; Alahdab, F.; Al-Mallah, M. H.; Vanderver, M. D.; Ficaro, E. P.; Murthy, V. L.\nScore: 1.2, Published: 2023-10-25 DOI: 10.1101/2023.10.25.23297552\nBackground: Impaired microvascular and vasomotor function is a common consequence of aging, diabetes, and other risk factors, and is associated with adverse cardiac outcomes. Such impairments are not readily identified by standard clinical methods of cardiovascular testing such as coronary angiography and noninvasive single photon emission tomography (SPECT) myocardial perfusion imaging (MPI). We hypothesized that signals embedded within stress electrocardiograms (ECGs) identify individuals with microvascular and vasomotor dysfunction. Methods: We developed and validated a novel convolutional neural network (CNN) using stress and rest ECG data (ECG-Flow) to identify patients with impaired myocardial flow reserve (MFR) on quantitative positron emission tomography (PET) MPI (N=3887). Diagnostic accuracy was validated with an internal holdout set of patients undergoing stress PET MPI (N=963). The prognostic association of ECG-Flow with mortality was then evaluated in a separate cohort of patients undergoing SPECT MPI (N=5102). Results: ECG-Flow achieved good diagnostic accuracy for impaired MFR in the holdout PET cohort (AUC, sensitivity, specificity: 0.737, 71.1%, 65.7%). Abnormal ECG-Flow was found to be significantly associated with mortality in both PET holdout and SPECT MPI cohorts (adjusted HR 2.12 [95% CI 1.45, 2.10], p=0.0001, and 2.07 [1.82, 2.36], p\u003c0.0001, respectively). Conclusion: Signals predictive of microvascular and vasomotor dysfunction are embedded in stress ECG waveforms. These signals can be identified by deep learning methods and are related to prognosis in patients undergoing both stress PET and SPECT MPI.\nMyocardial Characterization for Early Diagnosis, Treatment Response Monitoring, and Risk Assessment in Systemic Light-Chain Amyloidosis\nAuthors: Clerc, O. F.; Cuddy, S. A.; Jerosch-Herold, M.; Benz, D. C.; Katznelson, E.; Canseco Neri, J.; Taylor, A.; Kijewski, M. F.; Bianchi, G.; Ruberg, F. L.; Di Carli, M. F.; Liao, R.; Kwong, R. Y.; Falk, R. H.; Dorbala, S.\nScore: 1.5, Published: 2023-10-05 DOI: 10.1101/2023.10.04.23296572\nAbstractO_ST_ABSAimsC_ST_ABSIn systemic light-chain (AL) amyloidosis, cardiac involvement portends poor prognosis. Using myocardial characteristics on magnetic resonance imaging (MRI), this study aimed to detect early myocardial alterations, to analyze temporal changes with plasma cell therapy, and to predict risk of major adverse cardiac events (MACE) in AL amyloidosis. Methods and ResultsParticipants with recently diagnosed AL amyloidosis were prospectively enrolled. Presence of AL cardiomyopathy (AL-CMP vs. AL-non-CMP) was determined by abnormal cardiac biomarkers. MRI was performed at baseline and 6 months, with 12-month imaging in AL-CMP cohort. MACE was defined as all-cause death, heart failure hospitalization, or cardiac transplantation. Mayo AL stage was based on troponin T, NT-proBNP, and difference in free light chains. The study cohort included 80 participants (median age 62 years, 58% males). Median left ventricular extracellular volume (ECV) was significantly higher in AL-CMP (53% vs. 30%, p\u003c0.001). ECV was abnormal (\u003e32%) in all AL-CMP and in 47% of AL-non-CMP. ECV tended to increase at 6 months and decreased significantly from 6 to 12 months in AL-CMP (median -3%, p=0.011). ECV was strongly associated with MACE (p\u003c0.001), and improved MACE prediction when added to Mayo AL stage (p=0.002). ECV[\u0026le;]32% identified a cohort without MACE, while ECV\u003e48% identified a cohort with 74% MACE. ConclusionsIn AL amyloidosis, ECV detects subclinical cardiomyopathy. ECV tends to increase from baseline to 6 months and decreases significantly from 6 and 12 months of plasma cell therapy in AL-CMP. ECV provides excellent risk stratification and offers additional prognostic performance over Mayo AL stage.\nChineseCVD: first-in-world, web-based, Chinese-specific Cardiovascular Risk Calculator incorporating long COVID, COVID-19 vaccination, SGLT2i and PCSK9i treatment effects\nAuthors: Chang, C.; Tse, G.; Lee, Q.; Chou, O. H. I.; Lee, T. T. L.; Leung, B. K.-h.; Ngai, A. L.; Khan, A.; Wong, W. T.; Wai, A. K. C.; Chen, K. Y.; Liu, T.; Zhou, J.\nScore: 1.0, Published: 2023-10-28 DOI: 10.1101/2023.10.27.23297656\nBackground: Web-based risk prediction tools for cardiovascular diseases are crucial for providing rapid risk estimates for busy clinicians, but there is none available specifically for Chinese subjects. This study developed ChineseCVD, first-in-world web-based Chinese-specific Cardiovascular Risk Calculator incorporating long COVID, COVID-19 vaccination, SGLT2i and PCSK9i treatment effects. Methods: Adult patients attending government-funded family medicine clinics in Hong Kong between 1st January 2000 and 31st December 2003 were included. The primary outcome was major adverse cardiovascular events (MACE) defined as a composite of myocardial infarction, heart failure, transient ischaemic attacks/ischaemic strokes, and cardiovascular mortality. Results: A total of 155,066 patients were used as the derivation cohort. Over a median follow-up of 16.1 (11.6-17.8) years, 31,061 (20.44%) had MACE. Cox regression identified male gender, age, comorbidities, cardiovascular medications, systolic and diastolic blood pressure, and laboratory test results (neutrophil-lymphocyte ratio, creatinine, ALP, AST, ALT, HbA1c, fasting glucose, triglyceride, LDL and HDL) as significant predictors of the above outcomes. ChineseCVD further incorporates the impact of smoking status, COVID-19 infection, number of COVID-19 vaccination doses, and modifier effects of newest medication classes of PCSK9i and SGLT2i. The calculator enables clinicians to demonstrate to patients how risks vary with different medications. Conclusions: The ChineseCVD risk calculator enables rapid web-based risk assessment for adverse cardiovascular outcomes, thereby facilitating clinical decision-making at the bedside or in the clinic.\n",
  "wordCount" : "862",
  "inLanguage": "en",
  "datePublished": "2023-10-29T10:37:40Z",
  "dateModified": "2023-10-29T10:37:40Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/cardiovascular-medicine/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      cardiovascular medicine
    </h1>
    <div class="post-meta"><span>updated on October 29, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.25.23297552">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.25.23297552" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.25.23297552">
        <p class="paperTitle">Deep neural network for identification of impaired microvascular and vasomotor function from stress electrocardiography</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.25.23297552" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.25.23297552" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Moody, J. B.; Poitrasson-Riviere, A.; Renaud, J. M.; Hagio, T.; Alahdab, F.; Al-Mallah, M. H.; Vanderver, M. D.; Ficaro, E. P.; Murthy, V. L.</p>
        <p class="info">Score: 1.2, Published: 2023-10-25 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.25.23297552' target='https://doi.org/10.1101/2023.10.25.23297552'> 10.1101/2023.10.25.23297552</a></p>
        <p class="abstract">Background: Impaired microvascular and vasomotor function is a common consequence of aging, diabetes, and other risk factors, and is associated with adverse cardiac outcomes. Such impairments are not readily identified by standard clinical methods of cardiovascular testing such as coronary angiography and noninvasive single photon emission tomography (SPECT) myocardial perfusion imaging (MPI). We hypothesized that signals embedded within stress electrocardiograms (ECGs) identify individuals with microvascular and vasomotor dysfunction. Methods: We developed and validated a novel convolutional neural network (CNN) using stress and rest ECG data (ECG-Flow) to identify patients with impaired myocardial flow reserve (MFR) on quantitative positron emission tomography (PET) MPI (N=3887). Diagnostic accuracy was validated with an internal holdout set of patients undergoing stress PET MPI (N=963). The prognostic association of ECG-Flow with mortality was then evaluated in a separate cohort of patients undergoing SPECT MPI (N=5102). Results: ECG-Flow achieved good diagnostic accuracy for impaired MFR in the holdout PET cohort (AUC, sensitivity, specificity: 0.737, 71.1%, 65.7%). Abnormal ECG-Flow was found to be significantly associated with mortality in both PET holdout and SPECT MPI cohorts (adjusted HR 2.12 [95% CI 1.45, 2.10], p=0.0001, and 2.07 [1.82, 2.36], p&lt;0.0001, respectively). Conclusion: Signals predictive of microvascular and vasomotor dysfunction are embedded in stress ECG waveforms. These signals can be identified by deep learning methods and are related to prognosis in patients undergoing both stress PET and SPECT MPI.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.04.23296572">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.04.23296572" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.04.23296572">
        <p class="paperTitle">Myocardial Characterization for Early Diagnosis, Treatment Response Monitoring, and Risk Assessment in Systemic Light-Chain Amyloidosis</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.04.23296572" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.04.23296572" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Clerc, O. F.; Cuddy, S. A.; Jerosch-Herold, M.; Benz, D. C.; Katznelson, E.; Canseco Neri, J.; Taylor, A.; Kijewski, M. F.; Bianchi, G.; Ruberg, F. L.; Di Carli, M. F.; Liao, R.; Kwong, R. Y.; Falk, R. H.; Dorbala, S.</p>
        <p class="info">Score: 1.5, Published: 2023-10-05 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.04.23296572' target='https://doi.org/10.1101/2023.10.04.23296572'> 10.1101/2023.10.04.23296572</a></p>
        <p class="abstract">AbstractO_ST_ABSAimsC_ST_ABSIn systemic light-chain (AL) amyloidosis, cardiac involvement portends poor prognosis. Using myocardial characteristics on magnetic resonance imaging (MRI), this study aimed to detect early myocardial alterations, to analyze temporal changes with plasma cell therapy, and to predict risk of major adverse cardiac events (MACE) in AL amyloidosis.

Methods and ResultsParticipants with recently diagnosed AL amyloidosis were prospectively enrolled. Presence of AL cardiomyopathy (AL-CMP vs. AL-non-CMP) was determined by abnormal cardiac biomarkers. MRI was performed at baseline and 6 months, with 12-month imaging in AL-CMP cohort. MACE was defined as all-cause death, heart failure hospitalization, or cardiac transplantation. Mayo AL stage was based on troponin T, NT-proBNP, and difference in free light chains. The study cohort included 80 participants (median age 62 years, 58% males). Median left ventricular extracellular volume (ECV) was significantly higher in AL-CMP (53% vs. 30%, p&lt;0.001). ECV was abnormal (&gt;32%) in all AL-CMP and in 47% of AL-non-CMP. ECV tended to increase at 6 months and decreased significantly from 6 to 12 months in AL-CMP (median -3%, p=0.011). ECV was strongly associated with MACE (p&lt;0.001), and improved MACE prediction when added to Mayo AL stage (p=0.002). ECV[&amp;le;]32% identified a cohort without MACE, while ECV&gt;48% identified a cohort with 74% MACE.

ConclusionsIn AL amyloidosis, ECV detects subclinical cardiomyopathy. ECV tends to increase from baseline to 6 months and decreases significantly from 6 and 12 months of plasma cell therapy in AL-CMP. ECV provides excellent risk stratification and offers additional prognostic performance over Mayo AL stage.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.27.23297656">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.27.23297656" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.27.23297656">
        <p class="paperTitle">ChineseCVD: first-in-world, web-based, Chinese-specific Cardiovascular Risk Calculator incorporating long COVID, COVID-19 vaccination, SGLT2i and PCSK9i treatment effects</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.27.23297656" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.27.23297656" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Chang, C.; Tse, G.; Lee, Q.; Chou, O. H. I.; Lee, T. T. L.; Leung, B. K.-h.; Ngai, A. L.; Khan, A.; Wong, W. T.; Wai, A. K. C.; Chen, K. Y.; Liu, T.; Zhou, J.</p>
        <p class="info">Score: 1.0, Published: 2023-10-28 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.27.23297656' target='https://doi.org/10.1101/2023.10.27.23297656'> 10.1101/2023.10.27.23297656</a></p>
        <p class="abstract">Background: Web-based risk prediction tools for cardiovascular diseases are crucial for providing rapid risk estimates for busy clinicians, but there is none available specifically for Chinese subjects. This study developed ChineseCVD, first-in-world web-based Chinese-specific Cardiovascular Risk Calculator incorporating long COVID, COVID-19 vaccination, SGLT2i and PCSK9i treatment effects. Methods: Adult patients attending government-funded family medicine clinics in Hong Kong between 1st January 2000 and 31st December 2003 were included. The primary outcome was major adverse cardiovascular events (MACE) defined as a composite of myocardial infarction, heart failure, transient ischaemic attacks/ischaemic strokes, and cardiovascular mortality. Results: A total of 155,066 patients were used as the derivation cohort. Over a median follow-up of 16.1 (11.6-17.8) years, 31,061 (20.44%) had MACE. Cox regression identified male gender, age, comorbidities, cardiovascular medications, systolic and diastolic blood pressure, and laboratory test results (neutrophil-lymphocyte ratio, creatinine, ALP, AST, ALT, HbA1c, fasting glucose, triglyceride, LDL and HDL) as significant predictors of the above outcomes. ChineseCVD further incorporates the impact of smoking status, COVID-19 infection, number of COVID-19 vaccination doses, and modifier effects of newest medication classes of PCSK9i and SGLT2i. The calculator enables clinicians to demonstrate to patients how risks vary with different medications. Conclusions: The ChineseCVD risk calculator enables rapid web-based risk assessment for adverse cardiovascular outcomes, thereby facilitating clinical decision-making at the bedside or in the clinic.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
